In October of 2019 MSB raised $75M to build product inventory and targeted US based sales force in preparation for aGVHD launch. (7 months ago)
aGVHD Funded.
Last week MSB raised $138M (AUD) to scale up manufacturing for Rem_l for ARDS.
Therefore, in my opinion, current trials is most likely showing significant results, even at these early stages, using the Bayesian Predictive Probabilities. I believe the FDA will soon officially give MSB the green light to use Rem_l for ARDS.
Furthermore, I would not be surprised the SP closes higher or worst case down by no less than 3.40, Monday.
Again, this is my read of the current situation with the available information in hand.
Capital raising
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |